Cora Capital Advisors’s Cidara Therapeutics CDTX Stock Holding History

Cora Capital Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,016	Closed	-$224K	–	138
2025 Q4	$224K	Buy	+1,016	New	+$164K	0.09%	114

Cora Capital Advisors's CDTX Position: Q1 2026 in Review

Cora Capital Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,016 shares — an estimated $224K sold.

Cora Capital Advisors first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $224K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Cora Capital Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Cora Capital Advisors sold 1,016 Cidara Therapeutics shares in Q1 2026, an estimated $224K.
Cora Capital Advisors first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Cora Capital Advisors's Cidara Therapeutics position peaked at $224K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Cora Capital Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.